These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 37199628)
1. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker. Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628 [TBL] [Abstract][Full Text] [Related]
2. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer. Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J Front Immunol; 2021; 12():812713. PubMed ID: 35069601 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma. Zhang X; Zhou Y; Hu J; Yu X; Xu H; Ba Z; Zhang H; Sun Y; Wang R; Du X; Mou R; Li X; Zhu J; Xie R BMC Cancer; 2023 Jun; 23(1):560. PubMed ID: 37330494 [TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related gene Huang S; Cai C; Zhou K; Wang X; Wang X; Cen D; Weng G Aging (Albany NY); 2023 Nov; 15(21):12314-12329. PubMed ID: 37938155 [TBL] [Abstract][Full Text] [Related]
5. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy. Yang Q; Zeng S; Liu W PeerJ; 2023; 11():e15019. PubMed ID: 36949759 [TBL] [Abstract][Full Text] [Related]
6. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker. Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W Front Immunol; 2021; 12():646523. PubMed ID: 33679809 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis. Liu P; Wang X; Pan L; Han B; He Z Front Immunol; 2022; 13():901784. PubMed ID: 35720327 [TBL] [Abstract][Full Text] [Related]
8. DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma. Gao F; Yuan Y; Ding Y; Li PY; Chang Y; He XX Curr Med Sci; 2023 Jun; 43(3):526-538. PubMed ID: 37286711 [TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-Related Gene Fang Z; Wang W; Liu Y; Hua J; Liang C; Liu J; Zhang B; Shi S; Yu X; Meng Q; Xu J Curr Oncol; 2023 Mar; 30(3):2997-3019. PubMed ID: 36975441 [TBL] [Abstract][Full Text] [Related]
10. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D Front Immunol; 2023; 14():1181370. PubMed ID: 37600770 [TBL] [Abstract][Full Text] [Related]
11. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data. Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720 [TBL] [Abstract][Full Text] [Related]
12. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer. Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment. Wu Z; Pan T; Li W; Zhang YH; Guo SH; Liu Y; Zhang L; Wang ZY Clin Transl Oncol; 2024 Oct; 26(10):2701-2717. PubMed ID: 38642258 [TBL] [Abstract][Full Text] [Related]
14. Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells. Peng Y; Shi R; Yang S; Zhu J Cancer Med; 2024 Jul; 13(14):e70012. PubMed ID: 39031012 [TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer. Chu B; Wang Y; Yang J; Dong B Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879 [TBL] [Abstract][Full Text] [Related]
16. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Zhang P; Zhao JH; Yuan LX; Ju LL; Wang HX; Wang F; Chen L; Cai WH Sci Rep; 2023 Oct; 13(1):17295. PubMed ID: 37828099 [TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
18. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. Yang L; Zhang Y; Wang Y; Jiang P; Liu F; Feng N Front Pharmacol; 2022; 13():938134. PubMed ID: 36210836 [TBL] [Abstract][Full Text] [Related]